Biogen Inc (NASDAQ:BIIB)

301.23
Delayed Data
As of Apr 03
 -3.96 / -1.30%
Today’s Change
215.78
Today|||52-Week Range
374.99
+1.52%
Year-to-Date
3 Warren Buffett Stocks I Absolutely, Positively Wouldn't Buy Right Now
Apr 05 / MotleyFool.com - Paid Partner Content
4 Reasons Drug Stocks Are a Buy Right Now
Mar 30 / MotleyFool.com - Paid Partner Content
Why Gilead Sciences Is the Hottest Stock to Buy Today
Apr 04 / MotleyFool.com - Paid Partner Content
Bristol Myers Squibb's Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA Approval
Mar 26 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Biogen
Apr 03 / MotleyFool.com - Paid Partner Content
4 Reasons Biotech Stocks Are a Buy Right Now
Mar 25 / MotleyFool.com - Paid Partner Content
Why Biogen Shares Rose 2.59% in March
Apr 02 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie vs. Biogen
Mar 24 / MotleyFool.com - Paid Partner Content
So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature
Apr 01 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close304.47
Today’s open303.70
Day’s range296.81 - 311.52
Volume1,422,849
Average volume (3 months)1,982,200
Market cap$53.0B
Data as of 4:32pm ET, 04/03/2020

Growth & Valuation

Earnings growth (last year)+45.55%
Earnings growth (this year)-2.99%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+5.49%
P/E ratio9.6
Price/Sales4.37
Price/Book3.97

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-9.49-3.48%
BMRNBiomarin Pharmaceuti...-1.85-2.15%
MRNAModerna Inc+1.64+4.94%
EXASExact Sciences Corp-1.85-3.21%
Data as of 4:07pm ET, 04/03/2020

Financials

Next reporting dateApril 22, 2020
EPS forecast (this quarter)$7.76
Annual revenue (last year)$12.7B
Annual profit (last year)$5.9B
Net profit margin46.32%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts